APA (7th ed.) Citation

A, L., DR, G., D, M., B, M., A, M., M, M., . . . M, B. (2025). Cefiderocol therapy among immunocompromised adult patients: A descriptive analysis from a prospective, multicentre cohort study. BMC infectious diseases, 25(1), 1339. https://doi.org/10.1186/s12879-025-11573-3

Chicago Style (17th ed.) Citation

A, Lombardi, et al. "Cefiderocol Therapy Among Immunocompromised Adult Patients: A Descriptive Analysis from a Prospective, Multicentre Cohort Study." BMC Infectious Diseases 25, no. 1 (2025): 1339. https://doi.org/10.1186/s12879-025-11573-3.

MLA (9th ed.) Citation

A, Lombardi, et al. "Cefiderocol Therapy Among Immunocompromised Adult Patients: A Descriptive Analysis from a Prospective, Multicentre Cohort Study." BMC Infectious Diseases, vol. 25, no. 1, 2025, p. 1339, https://doi.org/10.1186/s12879-025-11573-3.